Literature DB >> 19870778

IMMUNIZATION OF GUINEA PIGS AGAINST LYMPHOCYTIC CHORIOMENINGITIS WITH FORMOLIZED TISSUE VACCINES.

E Traub1.   

Abstract

Guinea pigs can be immunized against lymphocytic choriomeningitis by 2 or 3 injections with formolized vaccines prepared from a variety of infected guinea pig tissues. Vaccines prepared from the consolidated areas of diseased lungs gave the best results. The immunity produced was partial in the majority of the cases, in that the vaccinated animals as a rule showed fever after the test of immunity and virus was present in the circulation during the febrile period. Vaccines prepared from infected mouse tissue had no, or very little, immunizing power for guinea pigs, even when prior to formolization they contained at least as much virus as guinea pig tissue vaccines. This failure to immunize appears to be due to the interference by heterologous antigens, since the immunity induced by homologous vaccines was often inhibited when formolized normal mouse tissue suspensions treated in the same manner as the guinea pig tissue vaccines were added to the latter before inoculation. The inhibitory effect of the heterologous tissue was less marked when it was not mixed with the vaccine but injected simultaneously on the opposite side of the body. The immunizing power of homologous vaccines did not parallel their virus content prior to formolization. A high degree of immunity, characterized by protective antibodies in the serum, was produced in some guinea pigs by prolonged treatment with large doses of homologous vaccine, while sera of guinea pigs vaccinated in the ordinary manner contained no detectable neutralizing antibodies. It is possible, therefore, that the immunity produced by inactive virus differs only quantitatively from that induced by an infection.

Entities:  

Year:  1938        PMID: 19870778      PMCID: PMC2133657          DOI: 10.1084/jem.68.1.95

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  PERSISTENCE OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN IMMUNE ANIMALS AND ITS RELATION TO IMMUNITY.

Authors:  E Traub
Journal:  J Exp Med       Date:  1936-05-31       Impact factor: 14.307

2.  IMMUNIZATION OF GUINEA PIGS WITH A MODIFIED STRAIN OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS.

Authors:  E Traub
Journal:  J Exp Med       Date:  1937-08-31       Impact factor: 14.307

  2 in total
  3 in total

1.  [Complement-fixing antibodies against the virus of lymphocytic choriomeningitis in serum of test animals and observation on immunity].

Authors:  I HANSEN; K A JOCHHEIM; G LIEDTKE; W SCHEID; G STAUSBERG
Journal:  Arch Gesamte Virusforsch       Date:  1957

2.  THE INACTIVATION OF THE VIRUS OF LYMPHOCYTIC CHORIOMENINGITIS BY SOAPS.

Authors:  C C Stock; T Francis
Journal:  J Exp Med       Date:  1943-04-01       Impact factor: 14.307

3.  A SOLUBLE ANTIGEN OF LYMPHOCYTIC CHORIOMENINGITIS : II. INDEPENDENCE OF ANTI-SOLUBLE SUBSTANCE ANTIBODIES AND NEUTRALIZING ANTIBODIES, AND THE ROLE OF SOLUBLE ANTIGEN AND INACTIVE VIRUS IN IMMUNITY TO INFECTION.

Authors:  J E Smadel; M J Wall
Journal:  J Exp Med       Date:  1940-09-30       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.